Program Committee
-
Yuji Kumagai, MD, PhD Professor, Kitasato Clinical Research Center
Kitasato University Hospital, Japan -
Keiichi Inaizumi, MSc Clinical Study Innovation Lead, Clinical Project Management Group
Pfizer R&D Japan, Japan -
Taro Amagasaki, PhD Head, Analytics Japan
Novartis Pharma K.K., Japan -
Nobuyuki Hanamura, PhD, MBA Senior Director, Clinical Operations
IQVIA, Japan -
Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Yayoi Kitawaki, MS Department Head, Neuroscience, GTx Development Unit
Novartis Pharma K.K., Japan -
Yoshiko Komuro, PhD Inspection Director, Office of Non-Clinical and Clinical Compliance
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?